Welcome to the Resveratrol News Network
This News Network is designed to help people track and share news about Resveratrol.
Resveratrol
0
Clips
Huffington Post:
Last night, at my son's 3rd grade pot luck, while munching on spicy sesame noodles and sipping red wine, I got into an animated conversation with a mom I'd never talked to before about personal branding. She's in between jobs, had worked in 2 different sectors before, and was now figuring out the best way to position hersel (Read More)
0
Clips
The Economist:
Toyota spent the most on research and development (R&D) of any company in the world in 2008, according to the European Commission’s latest tally. The Japanese carmaker increased its annual R&D spending by 7.6% to €7.6 billion ($10.6 billion), knocking Microsoft off the top spot. Three of the five biggest spenders are carmak (Read More)
Topics:
Pharmaceutical,
Research
0
Clips
L.A. Times - Europe:
Wine aficionados and Francophiles can head to the Roosevelt Hotel in Hollywood for a night of drinks and dance. The French government had to invent a holiday for it, but now it's taken on the patina of tradition. Every year at midnight on (Read More)
0
Clips
The Huffington Post | Full News Feed:
Washington Redskins kick returner Rock Cartwright remembers his brain "shaking like a bell" when he was walloped in a game against the New York Giants a few years ago."You know how a bell vibrates? That's how my brain was going at that time," he said. "I think five minutes later, I came back to myself. I went back out there (Read More)
0
Clips
The Huffington Post | Full News Feed:
MARIETTA, Pa. — Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler's diarrhea. You name it, the pharmaceutical industry is working on a vaccine to prevent it.Many could be on the market in five years or less. Contrast that with five year (Read More)
Topics:
Pharmaceutical,
Research
0
Clips
The Huffington Post | Full News Feed:
Major pharmaceutical companies have insisted for weeks, if not months, that the passage of health care reform would hurt their bottom lines. During an appearance at Bloomberg's Washington Summit last week, David Brennan, head of pharma giant AstraZeneca, said that it was "not obvious" to him "that there is an upside" to hea (Read More)
Topics:
Pharmaceutical,
Research
0
Clips
Daily Kos:
Last week Jon Cohn and Sam Stein reported on a just how much of a sweetheart deal PhRMA actually got by negotiating with Baucus and the White House on reform efforts. In return for the $80 billion in reduced payments to drug makers over the next decade, the industry stands nonethless to profit handsomely, as much as $137 bi (Read More)
Topics:
Pharmaceutical,
Research
0
Clips
Pune-Cities-The Times of India:
The Ranbaxy Science Scholar 2009 award for Pharmaceutical Sciences has been conferred upon Gaurav Vadnerkar, a National Doctoral Fellow of AICTE and research scholar at the Department of Pharmaceutical Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth University, Pune. (Read More)
Topics:
Pharmaceutical,
Research
0
Clips
The Huffington Post | Full News Feed:
The CEO of one of the biggest pharmaceutical companies in the country said on Friday that he and others in the industry would switch their support for health care reform to opposition if Congress settles on legislation passed by the House of Representatives.David Brennan, head of pharma giant AstraZeneca, told the Huffingto (Read More)
Topics:
Pharmaceutical,
Research
0
Clips
National Review Online:
This summer, just when the health-care debate grew sour, Big Pharma struck a sweet deal. Or so they thought. By agreeing to pony up $80 billion to support Obamacare, the Pharmaceutical Research and Manufacturers of America, or PhRMA, assumed that they dodged a bullet. Ladle the Democrats some cash now, they reckoned, and ma (Read More)
Topics:
Pharmaceutical,
Research
0
Clips
The Huffington Post | Full News Feed:
PhRMA Statement on Prescription Medicines SpendingWashington, D.C. (November 11, 2009) -- Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement today regarding IMS Health's revised forecast for prescription medicine sales growth in the U.S.:"Online stor (Read More)
Topics:
Pharmaceutical,
Research
0
Clips
New York Times:
The effect, though not as pronounced as with red wine, was seen in a Spanish study.
. (Read More)
0
Clips
L.A. Times - Movie News:
American's ear for dialect makes him an in-demand character actor. He's Irish in the upcoming 'Turning Green.' "I don't see myself as having any integrity at all," says Alessandro Nivola through his roguish, close-toothed smile, toying wi (Read More)
0
Clips
Huffington Post:
Michelle Locke, AP:What goes well with Slim Jims and Slurpees? 7-Eleven wine, naturally.The convenience store chain announced Tuesday it is getting into the value wine business, releasing two low-priced proprietary wines in the United States and Japan.Sold under the Yosemite Road label, the California wines, a chardonnay an (Read More)
0
Clips
Apartment Therapy Main:
I have a wise friend who insists upon upholstering her furniture in colors of the party food/drinks she serves most often. Regretfully, we ignored her advice when buying our immaculately white sofa, however in our on-going effort to party-proof our home we're seriously considering turning all our old fabric scraps into (Read More)
Add something
invite your friends to the "Resveratrol" News Network
Info and Settings
Created by: Eric Egnet
Created on:
Dec 24, 2008
News Network Members (1)
Topics
Use the arrows to adjust the relevance rankings.
(primary topic)
Sources
Use the arrows to adjust relevance rankings.
|
||
|
|
||
